StonvexLoading…
StonvexStonvexStonvexCore line items from NROM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $11.98M | $7.84M | $3.76M | $15.15M |
Operating Income | $2.23M | $1.42M | $501.64K | $1.48M |
Net Income | $1.14M | $501.51K | $130.63K | $-3.17K |
EPS (Diluted) | $0.04 | $0.02 | $0.01 | $0.00 |
Total Assets | $16.08M | $16.23M | $16.29M | $16.77M |
Total Liabilities | $12.70M | $13.49M | $13.93M | $14.55M |
Cash & Equivalents | $719.50K | $635.63K | $564.64K | $710.23K |
Free Cash Flow OCF − CapEx | $801.16K | $492.29K | $138.69K | Not available |
Shares Outstanding | 22.22M | 22.22M | 22.22M | 22.22M |